A manual ELISA-based diagnostic test for the tumor marker MonoTotal. This product is part of IDL Biotech's manual ELISA tumor marker portfolio licensed to Beckman Coulter Diagnostics.
Manufactured by
Bromma, Sweden
IDL Diagnostics is a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics targets different patient groups in different parts of the world. With an organization that occupies the entire value chain from R D to manufacturing and marketing, we have the flexibility of a small company and the characteristics of a big company. It enables us to be a fast mover in the fast growing field of IVD-tests This is critical for us to be able deliver on our vision to be valuable and relevant diagnostic partner in oncology healthcare. Based on our proprietary technologies and our biomarkers, we develop tests that are clinically useful and economically viable, making us a valuable and relevant diagnostic partner for healthcare professionals. We provide rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, and easy to perform – all of which are important criteria for the healthcare and payer community. At IDL Diagnostics, we are proud that our diagnostic solutions can contribute to one of the three imperatives for reducing the burden of disease: diagnostics, therapeutics and vaccines. In the wake of covid-19, it is fair to say that diagnostics has been given a well-deserved place in the healthcare limelight. With a growing number of elderly people around the world in combination with an increase in the incidence of chronic diseases, the need for accurate diagnostics is essential. We create value for our shareholders by executing our strategy of increasing sales volumes in existing markets, obtaining market approvals in other prioritized markets, and continuously developing the next generation of IVD tests. With a pipeline that meets current and future demands, we stay relevant not only to patients, but to all our stakeholders. IDL Diagnostics was first listed in 2016 and our shares are traded on Stockholm Nasdaq First North.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Beijing Hotgen Biotech Co.,Ltd
China · 2 relevant products
Vitrotest Bioreagent LLC
Ukraine · 2 relevant products
IBL-America
United States · 2 relevant products
Xema Oy
Finland · 1 relevant product
Reddot Biotech Inc.
United States · 1 relevant product
Diagnostics Biochem Canada Inc.
Canada · 1 relevant product
Pishtaz Teb Zaman Diagnostics PJS
Iran · 1 relevant product
Nantong Egens Biotechnology Co., Ltd.
China · 1 relevant product
EPITOPE DIAGNOSTICS, INC.
United States · 2 relevant products
J. Mitra & Co. Pvt. Ltd.
India · 2 relevant products
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 99 closest product alternatives
Beijing Hotgen Biotech Co.,Ltd · China
ELISA-based diagnostic kit for tumor marker detection and quantification. Supports cancer screening and monitoring in laboratory settings.
Vitrotest Bioreagent LLC · Ukraine
ELISA test kit for the quantitative determination of tumor markers in human serum or plasma. Supports oncology laboratory diagnostics and cancer screening.
IBL-America · United States
In vitro diagnostic ELISA kit for direct quantitative determination of total estrogens in human serum. Measures combined levels of estrone, estradiol, and estriol with 510(k) exemption.
IBL-America · United States
An assay kit for the determination of Total Estrogens in human serum. This diagnostic test is designed for quantitative measurement of estrogen levels in clinical and research applications.
Xema Oy · Finland
ELISA test kits for in vitro diagnostics of human diseases, including determination of tumor markers, hormones, infection markers, and humoral immunity parameters. These tests are designed for clinical diagnostic applications in human medicine.
Reddot Biotech Inc. · United States
ELISA kit designed for the detection and quantification of tumor necrosis factor in biological samples. Delivers precise measurement capabilities for inflammatory response research.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of total thyroxine (T4) in human serum samples. The assay has an assay time of 50 minutes, a shelf stability of 18 months, and a sensitivity of 0.6 μg%. Reference: CAN-T4-4240.
Vitrotest Bioreagent LLC · Ukraine
ELISA test kits for quantitative and qualitative analysis of biomarkers in human serum and plasma samples. These immunoassay kits support thyroid function screening, endocrine panel testing, and clinical diagnostics in laboratory settings. Each kit includes calibrators, controls, and reagents for reliable results with established protocols.
Pishtaz Teb Zaman Diagnostics PJS · Iran
ELISA diagnostic test products for laboratory use in medical diagnostics and analysis.
Nantong Egens Biotechnology Co., Ltd. · China
In vitro diagnostic kits for detection and quantification of cancer biomarkers in patient samples. Available in multiple formats including ELISA and CLIA for oncology applications.
EPITOPE DIAGNOSTICS, INC. · United States
ECL100 tumor marker portfolio delivers electrochemiluminescence-based immunoassays for quantitative detection of cancer biomarkers. This ELISA kit system enables clinical laboratories to assess tumor markers for oncology screening, diagnosis, and patient monitoring. The assay provides sensitive, specific results with standardized protocols suitable for high-throughput diagnostic workflows.
J. Mitra & Co. Pvt. Ltd. · India
T3 Quanti Microlisa is an ELISA-based immunoassay for quantitative measurement of total triiodothyronine (T3) in serum. Used for thyroid function assessment and diagnosis of thyroid disorders, the kit offers high sensitivity and specificity for reliable clinical results.
87 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products